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Bovine herpesvirus 1 (BHV-1) glycoprotein B (gB) has been shown to interact with two types of receptor on Madin Darby
bovine kidney cells. The first receptor is heparan sulfate proteoglycan, whereas the second high-affinity receptor remains
unknown. In order to study the structural requirement for gB’s high-affinity binding activity, different forms of the gB
ectodomain were expressed and compared with authentic gB. By using chemical cross-linking and sucrose gradient centrifu-
gation, we found that BHV-1 gB was able to form dimers. A region between the cleavage site and the transmembrane
anchor region, residues 506 to 763, was found to be required for gB oligomerization. Although the purified gBt and gBtM,
two truncated forms of gB, formed oligomers, they did not block the high-affinity cellular receptor, suggesting that oligomeriza-
tion was not the reason for the loss of the high-affinity binding site on gB. However, an N-terminal juxtamembrane region-
located epitope recognized by a monoclonal antibody, designated epitope I, was lost from gBt and gBtM, indicating that
both truncated gBs are conformationally changed. Therefore, the structure around this particular region may be required
for the existence of the gB high-affinity binding site. q 1996 Academic Press, Inc.
The early entry of herpesviruses is mediated by the dimers (8–12). The oligomerization is necessary for the
production of infectious virus, since in the temperature-interactions of viral glycoproteins and receptors on the
cell surface (1). In bovine herpesvirus type 1 (BHV-1), sensitive HSV isolates, gB failed to form dimers at the
nonpermissive temperature (13, 14). In order to studythree major glycoproteins, gB, gC, and gD, have been
shown to be involved in such a process (2, 3). Among the structural requirement of the BHV-1 gB high-affinity
binding site, we focused on the oligomerization and con-them, gB can bind to two different cellular receptors,
heparan sulfate (HS) and a non-HS component (3). Pre- formation of the truncated gB (gBt), which was previously
shown to have no high-affinity binding site. A previouslyviously, it was found that the N-terminal subunit, gBb,
is required for HS binding (4). However, the structure expressed N-terminal subunit, gBb, was also included in
the present study as a control. Truncations in the C-responsible for high-affinity binding of gB to the non-
HS receptor has not been identified yet, although such terminal region of gB may preclude overall oligomer for-
mation (15), which in turn may influence the functionbinding has been suggested to be important for the infec-
tivity of BHV-1 (3). of gB. Therefore, we compared the authentic gB and
truncated forms for their oligomer formation and abilityAs one of the essential viral glycoproteins, gB homo-
logues of herpesviruses play an important role in virus to block BHV-1 plaque formation, which is correlated with
the existence of a high-affinity binding site of gB.penetration (1, 5). The functions of gB have been shown
to have strict structural requirements (6–8), which may BHV-1 gB is synthesized as a 933-amino-acid precur-
sor, which is subsequently cleaved into two subunits.include oligomerization and proper folding. In herpes
simplex virus (HSV), pseudorabies virus (PRV), and hu- According to amino acid sequence analysis, the pre-
dicted transmembrane region is located between resi-man cytomegalovirus (HCMV), gB homologues exist as
dues 759 and 828 (16, 17). Previously, we expressed gBt,
a truncated gB without the putative transmembrane and1 Published as VIDO journal series No. 213.
2 Current address: Department of Cellular and Molecular Biology, cytoplasmic regions, in MDBK cells by using the bovine
Merck Research Laboratories, 126 East Lincoln Avenue, Rahway, NJ hsp70A gene promoter (3). The recombinant gBt retained
07065-0912. the heparin-binding function, but not the high-affinity3 To whom correspondence and reprint requests should be ad-
binding function (3, 4). Based on the assumption thatdressed at The Veterinary Infectious Disease Organization, University
high-affinity binding is mediated by the extracellular por-of Saskatchewan, 120 Veterinary Road, Saskatoon, Saskatchewan,
Canada S7N 5E3. Fax: (306) 966-7478. tion of gB, in the present study, an extended form of the
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FIG. 1. Schematic diagram (A) and immunoprecipitation (B) of BHV-1 gB and truncated derivatives. (A) BHV-1 gB is represented as a box structure
in which the signal sequence (S) and transmembrane anchor region (TMA) are shaded. Amino acid sequences for both termini of the truncated
gB’s are presented with the corresponding residue number. The amino acids of gBtM that are given in parentheses are exogenous residues added
during construction of the molecule. (B) After labeling with [35S]Met/Cys, the labeled cells (C) and the media (M) were collected separately and
precipitated with a gB-specific monoclonal antibody pool (32). The samples were boiled for 5 min and then separated on SDS–8.5% polyacrylamide
gels under reducing conditions (with 2-mercaptoethanol). Lane gB is the sample from the wild-type (wt) BHV-1-infected MDBK cells; lanes gBb, gBt,
and gBtM are samples from the corresponding transfected MDBK cell lines which express gBb, gBt and gBtM, respectively. Molecular mass markers
(kDa) are shown on the right.
truncated gB, gBtM, was expressed in order to produce cleaved N-terminal subunits are in the same position
in the SDS gel as the authentic gBb (lane gB) and thethe entire ectodomain. This truncated form of gB stops
after residue 807, such that it contains two-thirds of the recombinant gBb (lane gBb). The authentic gB’s C-termi-
nal subunit, gBc, has a molecular weight of about 55putative transmembrane region of gB. Studies of HSV gB
have demonstrated that the 69-amino-acid transmem- kDa. For gBt, a 38-kDa band was found, whereas for
gBtM, a 42-kDa band was observed. The reduced molec-brane region can be divided into three segments, in
which the C-terminal segment (segment 3) is sufficient ular weights of gBt and gBtM were attributed to the trun-
cation of their C-terminal region. Under nonreducing con-to be the membrane anchor and segment 2 has a weak
ability to retain the protein in the membrane (18, 19). ditions, by boiling for 5 min without 2-mercaptoethanol,
gBt and gBtM have expected molecular weights of aboutFrom sequence analysis, the corresponding segment 3
in BHV-1 gB has the highest hydrophobicity of the three 115 and 120 kDa, respectively (results not shown). Based
on their mobilities under reducing and nonreducing con-potential membrane-spanning segments, which may be
used as the real membrane anchor. Therefore, gBtM may ditions, we suspected that these recombinant forms of
gB are structurally similar to authentic gB.represent the entire extracellular portion of BHV-1 gB
(Fig. 1A). Immunoprecipitation studies have shown that authen-
tic gB was detected in the cell lysate, whereas all theThe expression of truncated gB derivatives in mamma-
lian cells is a good strategy for studying structural and recombinant gBs were detected both in the cell lysate
and in the medium. However, as shown in Fig. 1B, afterfunctional properties of gB without constructing viral mu-
tants, which has been used in HSV and HCMV (15, 20, overnight labeling, gBt, gBb, and gBtM were mostly pres-
ent in the medium (lanes M), whereas only trace amounts21). In our study, different forms of gB were expressed
under the control of the bovine hsp70A gene promoter of protein, primarily the precursor forms, were found in
the cells (lanes C), indicating that gBt, gBb, and gBtM(4, 22). After lipofectin-mediated transfection, the gB-ex-
pressing cells were cloned. All the gB-expressing cell are efficiently secreted from the cells. A pulse–chase
experiment also showed that both gBt and gBb are effi-lines exhibited morphology and growth properties similar
to those of the parental MDBK cells. To compare the ciently secreted whereas gBtM secretion into the me-
dium occurred at a slightly lower rate (result not shown).truncated gB products from different cell lines with the
authentic gB in BHV-1-infected cell lysate, [35S]- These results suggest that the first two segments of the
transmembrane region may provide unstable membranemethionine/cysteine (ICN, Mississauga, Ontario) -la-
beled samples were prepared and subjected to immuno- retention for the protein without the third segment of
the transmembrane region and the cytoplasmic domain,precipitation (4). Under reducing conditions, it was found
that both gBt and gBtM were cleaved (Fig. 1B) and the which is consistent with studies of HSV-1 and HCMV (18,
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23). Therefore, gBtM represents the whole ectodomain
of gB as we predicted and this product could be purified
from the culture medium.
In HSV, PRV, and HCMV, gB homologues have been
identified as dimeric oligomers (8–10, 24). Previous stud-
ies in HSV-1 showed that the gB homodimer was heat-
dissociable and detergent-resistant and that its dimeriza-
tion was not dependent on glycosylation or expression
of other viral proteins (10, 12). However, thus far there is
no evidence for oligomerization of BHV-1 gB. To examine
the oligomeric status of BHV-1 gB, we first subjected
the BHV-1-infected MDBK cells to a nonreversible cross-
linking agent, ethylene glycolbis(succinimidylsuccinate)
(EGS) (Pierce, Rockford, IL). The spacer arm length of
EGS is 6.1 A˚, which can cross-link closely associated
oligomers. The cross-linking was performed essentially
as described by Russel et al. (25). The overnight radiola-
beled infected cells were washed and collected in cold
phosphate-buffered saline (PBS), then dissolved in the
cross-linking buffer (PBS, 0.5% Nonidet P-40, 0.5% so-
dium deoxycholate, desired concentration of EGS). The
reaction was carried out at 47 for 1 hr and then quenched
with glycine at a final concentration of 100 mM. After
cross-linking, the sample was further treated with radio-
immunoprecipitation assay (RIPA) buffer and processed
as a normal immunoprecipitation assay (4). In the ab-
sence of the cross-linker, the monomeric precursor form
FIG. 2. Cross-linking of BHV-1 gB with ethylene glycolbis(succinimi-
and the mature gB are both detected by SDS–PAGE (Fig. dylsuccinate) (EGS). Radiolabeled wt BHV-1-infected MDBK cells were
2). With increasing concentrations of the cross-linker, a treated with different concentrations of EGS at 47C for 1 hr. After lysis
higher molecular weight band appeared at a position with RIPA, the samples were immunoprecipitated by the gB-specific
monoclonal antibody pool and separated on a SDS–5% polyacrylamidecorresponding to the dimer of gB (about 250 kDa) (Fig.
gel under nonreducing conditions. The molecular mass markers (kDa)2, arrow D). This band was situated in the separating
are shown on the right. D, dimer; M, monomer; P, precursor.
gel, and no protein bands could be seen above or at the
interface of the stacking and separating gels. Therefore,
it is believed that for BHV-1 gB, there are no other oligo- study. Without a chase, the majority of labeled gB existed
as a monomeric precursor at a position of approximatelymeric forms except that of a dimer. It also appeared that
in BHV-1-infected cells, after overnight labeling, most of 100 kDa (Fig. 3, BHV-1 gB, fractions 9–11). After a 15-
min chase, some of the monomeric precursor shifted tothe gB product existed as an oligomer. No monomeric
form was found when the EGS concentrations were a position of approximately 200 kDa, where the complete
glycosylated gB was also apparent (fractions 7–9). Afterhigher than 5 mM (Fig. 2).
To further assess the oligomerization status of authen- a 60-min chase, most labeled gB was present as a dimer
at the 250-kDa position (fraction 7). The gBt- and gBtM-tic gB and the recombinant derivatives, sucrose density
centrifugation was applied as described by Whealy et al. expressing cells had similar patterns in that after a 60-
min chase, both glycosylated gB products were found in(8). BHV-1-infected MDBK cells and gB-expressing MDBK
cells were pulse-labeled with 200 mCi of [35S]Met/Cys fraction 7 as dimers, whereas the monomeric precursor
forms were in fraction 11 (Fig. 3, gBt and gBtM). Thisper milliliter for 10 min and then chased for 15 or 60
min. The radiolabeled cell lysates were layered onto 5- result is consistent with HSV gB where it was shown
that the cytoplasmic and transmembrane anchor regionsml continuous 5–20% (W/V) sucrose gradients in lysis
buffer. The centrifugation was carried out for 16 hr at do not appear to be required for the oligomerization of
BHV-1 gB (15, 26, 27). However, in the gBb-expressing240,000 g in a SW50.1 rotor (Beckman Inc., Mississauga,
Ontario) at 47. A parallel tube with protein mass markers cells, a different pattern was observed, which showed
that the fully glycosylated product remained in the samewas included in each centrifugation. After centrifugation,
15 fractions were collected from the bottom. The entire fractions as the monomeric precursor form (Fig. 3, gBb,
fractions 11–13), suggesting that gBb did not form ansample in each fraction was subjected to immunoprecipi-
tation. The results confirmed that BHV-1 gB can form oligomeric structure. In HSV gB, two regions of the ecto-
domain, amino acids 93–282 and 596–711, have beendimers (Fig. 3, BHV-1 gB) as shown by the cross-linking
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FIG. 3. Sucrose gradient sedimentation study of BHV-1 gB and truncated gB derivatives. Wild-type BHV-1-infected MDBK cells or truncated gB-
expressing cells were pulse-labeled with 200 mCi/ml [35S]Met/Cys for 10 min at 6 hr postinfection, then chased for different intervals. The radiolabeled
cells were washed in PBS and lysed in 0.3 ml lysis buffer (50 mM Tris–HCl, pH 7.5, 5 mM EDTA, 150 mM NaCl, 1% Triton X-100). The samples
were layered onto 5-ml continuous 5–20% (W/V) sucrose gradients prepared in lysis buffer and centrifuged for 16 hr at 240,000 g (45,000 rpm).
After centrifugation, 15 fractions were collected from the bottom (fraction 1 is the first bottom fraction). All the fractions were subjected to immunopre-
cipitation and the precipitates were separated on a SDS–7.5% polyacrylamide gel. Protein markers were run in parallel and included ferritin (440
kDa), catalase (250 kDa), and hexokinase (100 kDa). Fractions containing the protein markers are indicated with arrows. The different chase intervals
(min) are indicated on the left and the molecular mass markers (kDa) are shown on the right.
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acted with authentic gB, whereas it failed to react with
the recombinant gBs. An ELISA test further suggested
that the differences in 1B10 reactivity between the recom-
binant gBs and authentic gB were not quantitative, but
qualitative (data not shown). This epitope has previously
been localized between residues 744 and 763 and has
previously been proven to be important for gBs fusion
activity (31, 32). The region containing this epitope repre-
sents a major hydrophilic peak in the ectodomain of gB.
Although we do not know whether 1B10 recognizes a
linear or a conformational epitope, it does not neutralize
virus. Both gBt (1–763) and gBtM (1–807) contain this
region; however, none of the recombinant gBs in this
study was recognized by monoclonal antibody 1B10.
Therefore, the inability of this antibody to recognize gBt
and gBtM was probably caused by improper folding of
the recombinant gBs.
Although gBtM represents the entire ectodomain of
BHV-1 gB, it retains structural properties similar to those
of gBt, and both products lost epitope I as a result of
conformational changes. We previously demonstrated
that gBt retains its HS-binding property but not the high-
affinity binding ability, which prevents the interaction of
gB with the high-affinity binding receptors on MDBK cells.
In the present study, gBtM was also purified by affinityFIG. 4. Immunoprecipitation of truncated gB derivatives with individ-
ual gB-specific monoclonal antibodies. The wt BHV-1-infected MDBK chromatography and used in a BHV-1 plaque inhibition
cells (gB) and the truncated gB expressing cells were radiolabeled. assay. Before the proteins were used in such an assay,
Samples of cell lysate and medium were combined and immunoprecipi-
their oligomerization status was examined by sucrosetated with individual gB-specific monoclonal antibodies. The antibodies
gradient centrifugation. It was found that with the excep-names and their corresponding epitopes are indicated on top. On the
tion of gBb, all the other gB products, gB, gBt, and gBtM,left the different gB derivatives are indicated.
remained as oligomeric forms after purification (result
not shown). Results of the plaque inhibition assay
showed that only authentic gB blocked BHV-1 plaquefound to be necessary for dimer formation (24). Others
confirmed that the region between amino acids 600 and formation, whereas all the truncated gBs failed to inhibit
BHV-1 plaque formation (Fig. 5). The difference in the690 was important for the dimerization (15, 26, 27). Com-
parison of the oligomer formation of gBt and gBb would plaque inhibition between authentic and truncated gBs
is not caused by the potential existence of detergentsuggest that residues 506 to 763 are important in the
oligomerization of BHV-1 gB. The potential oligomeriza- in the authentic preparation, since both authentic and
truncated gC and gD purified under these conditionstion domain(s) may be located in this region or it may
provide a conformational requirement for oligomer for- have been shown to inhibit BHV-1 plaque formation (3).
Therefore, like gBt, the newly generated entire gB ectodo-mation. A recent study provided strong evidence that in
HSV gB, a 28-amino-acid domain, residues 626 to 653, main gBtM may not have the high-affinity binding site.
From our previous results and current data, we canis responsible for gB oligomerization (28), which may
also suggest that in BHV-1 gB, an oligomerization domain draw a proposed pathway for BHV-1 gB maturation. The
newly synthesized gB precursor quickly forms an oligo-is located in the region between residues 506 and 763.
Previously, a panel of gB-specific monoclonal antibod- mer in the endoplasmic reticulum, which is transported to
the Golgi apparatus and undergoes further glycosylation,ies has been established and characterized (29–31).
Among these antibodies, some can recognize epitopes followed by proteolysis. gBt and gBtM are processed in
a similar way and are structurally similar to authentic gB,only after proper glycosylation or folding, which can be
used to identify the proper conformation of the proteins. including being oligomerized. However, unlike authentic
gB, they do not have the high-affinity binding site. TheIn order to compare authentic gB with the recombinant
forms of gB, 10 gB-specific monoclonal antibodies were most likely reason for loss of the high-affinity binding site
is that the cytoplasmic domain is important in main-used to precipitate the different gB products. Of the 10
monoclonal antibodies, one antibody, 1B10, which recog- taining the native conformation of gB. This contention is
supported by the loss of epitope I in the recombinantnizes epitope I of gB, had dramatically different reactivi-
ties with different forms of gB (Fig. 4). This antibody re- gBs. Although the entire cytoplasmic domain and the
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ration). However, gB-induced fusion may be controlled
by a complex series of events, the modulation. We specu-
late that during virus entry, in order to achieve the correct
configuration for inducing fusion, gB has to bind to the
non-HS receptor via its high-affinity binding site. There-
fore, the blockage of the high-affinity binding may pre-
clude the fusion process, which in turn may block virus
infection. Without the cytoplasmic region, the truncated
gBs cannot induce the correct conformation of the high-
affinity binding site. Thus they cannot block the corre-
sponding receptor on MDBK cells.
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